Arquivamento definitivo - Art. 33 da LPI
#11.1.1
10/17/2023
RPI 2754
Application data
Number
112022000328Type
Filing
Publication
PCT
US2020041409 The application was abandoned: examination was not requested within the 36 months following the 07/09/2020 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.
Talk to a specialistLatest action published by the INPI: 10/17/2023. We update with every new RPI gazette, published weekly.
Applicants
PROTAGONIST THERAPEUTICS, INC.
US
Inventors
A. B. (pessoa física)
US
B. F. (pessoa física)
US
D. S. (pessoa física)
US
IPC Classification
Priority claims
US
62/872,477 · 07/10/2019
Abstract
INIBIDORES PEPTÍDICOS DO RECEPTOR DE INTERLEUCINA-23 E SEU USO PARA TRATAR DOENÇAS INFLAMATÓRIAS. A presente invenção fornece novos inibidores peptídicos do receptor de interleucina-23 e composições e métodos relacionados do uso desses inibidores peptídicos para tratar ou prevenir uma variedade de doenças e distúrbios, incluindo doenças inflamatórias intestinais.
Publications in the Brazilian Industrial Property Gazette (RPI).
#11.1.1
10/17/2023
RPI 2754
#11.1
08/01/2023
RPI 2743
#1.3
03/15/2022
RPI 2671
#1.1
01/18/2022
RPI 2663
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.